1 Two other glucagon-like peptide-1 receptor agonist (GLP-1) medications, tirzepatide and liraglutide, have also been approved for weight loss by the FDA
Four-week trends tell the real story
Nonclinical Toxicology Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [5-, 17-, and 59-fold the maximum recommended human dose (MRHD) of 1 mg/week, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (2-, 5-, and 17-fold MRHD) were administered to the females
What are the potential side effects of Wegovy
Up to 10% of people get diarrhea when starting Amarasate, so its introduced gradually over 5 days